FDA clarifies policies for compounders as national GLP-1 supply …
The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved.
Research shows GLP-1 drugs are effective but complex - UChicago …
May 30, 2024 · While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment.
Science’s 2023 Breakthrough: GLP-1 Agonists Show Promise …
Dec 15, 2023 · Science has named the development of glucagon like peptide-1 (GLP-1) agonists — and this year's discovery that these drugs can blunt obesity-associated health problems — as its 2023 Breakthrough of the Year.
Special Report: Potential Strategies for Addressing GLP-1 and Dual …
Apr 7, 2023 · Unexpected drug shortages of the long-acting glucagon-like peptide 1 (GLP-1) receptor agonists dulaglutide and semaglutide and the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist tirzepatide emerged in late 2022 and have persisted through the first quarter of 2023 (1).
Science’s Breakthrough of the Year: GLP-1 agonists can blunt …
Dec 15, 2023 · Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year's discovery that these drugs can blunt obesity-associated health problems as its 2023...
GLP-1 Drug Liraglutide May Protect Against Dementia
PHILADELPHIA, July 30, 2024 — A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial data reported today at the Alzheimer’s Association International Conference ® (AAIC ®) …
Expert explores the expanding applications of GLP1 therapies
2 days ago · Clinical trials in 2024 highlight the expanded benefits of glucagon-like peptide 1-based medicines, extending beyond glucose control and weight loss to address various disorders. Study: Expanding ...
From diabetes drug to anti-inflammation powerhouse: The …
Dec 18, 2023 · Known as GLP-1 receptor agonists, for glucagon like peptide 1, these medications mimic the gut hormone GLP1, which regulates blood sugar levels and appetite. Among them are the popular weight...
Glucagon-like peptide-1 receptor: mechanisms and advances in …
Sep 18, 2024 · We introduce recent studies that demonstrate the remarkable performance of GLP-1RAs in slowing the progression of neurodegenerative diseases, reducing inflammation, and enhancing cardiovascular...
GLP-1 agonists: US sees 700% increase over four years in ... - The BMJ
Jul 23, 2024 · The number of patients without diabetes but with overweight or obesity who started glucagon like peptide-1 receptor agonist (GLP-1RA) treatment in the US has risen from around 21 000 in 2019 to over 174 000 in 2023—a rise of more than 700%—a study has found. 1
- Some results have been removed